with QA being overproduced and KYNA insufficient to counteract its excitotoxic effects, the susceptibility to and severity of epileptic seizures will increase
While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
Eckers, E., Bien, M., Stroobant, V., Herrmann, J
CE methods provide rapid separation times, low sample volume requirements, and compatibility with UV, fluorescence, and mass spectrometric detection